There are many reports of the experience of groups of patients with a bronchial carcinoma treated by lung resection. In this coun'try, for instance, there are series recorded by Sellors, Cruickshank, and Billimoria (1947) , Brock (1948) , Mason (1949), Taylor and Waterhouse (1950) , Price Thomas (1952), and Sellors (1955 Some were reported to have died from causes other than cancer, and in some of these postmortem examination showed no recurrence or metastases. But unless there is a high proportion of necropsies it is impossible to estimate accurately the frequency of non-cancer deaths; no distinction is made in this investigation between death from cancer and death from other diseases. The mortality rates, therefore, are for deaths from all causes. Patients living at the time of the last report were considered to have been alive for half the particular year of observation. The survival rates for the fourth and later years are less likely to be accurate than those for the first three, as the yearly number of operations increased considerably during the later part of the period.
There are many reports of the experience of groups of patients with a bronchial carcinoma treated by lung resection. In this coun'try, for instance, there are series recorded by Sellors, Cruickshank, and Billimoria (1947) , Brock (1948) , Mason (1949) , Taylor and Waterhouse (1950) , Price Thomas (1952) , and Sellors (1955) . But gross yearly survival rates may be a poor guide to prognosis in the individual patient if the duration of survival is greatly influenced by factors not common to all. We have investigated the effects on survival of some of these factors in a relatively large group of patients.
The patients were operated on at the Hospitals for Diseases of the Chest by the surgeons of the two hospitals and their assistants between 1940 and 1951. All with a histological diagnosis and a record of the cell type have been included.
Records of 531 patients were available; all but 13 (2%) were followed for at least two years or until death. Three were lost sight of during the first two months, two in the third month, and four more in the remaining nine months of the first year.
The experience of the patients is expressed as the chances of surviving for each of the first five years after operation. The survival rates have been calculated by the life-table method, which makes full use of the available data where groups of patients have been treated over a period of years and observed for different lengths of time. The validity of the procedure depends on the mortality remaining unchanged throughout the period. This was not true of the immediate mortality after operation. The " operative mortality," arbitrarily defined as death within two months of operation, was high in the early years. Between 1940 years. Between and 1946 years. Between it was 19%, but in 1947 fell to 16% and in the next two-year period to 10%. The opzrative mortality must therefore be removed from the life-tables, both for investigating the p factors influencing survival and for using the rates as a guide to the prognosis of patients operated on in the future. On the other hand, the experience of those who survived operation changed little during the 12 years (Table II) . Thus, for the 114 survivors during 1940-46 the chance of surviving two years was 47% and four years 34%. In the next period the corresponding rates were 48 % and 36% for 155 patients; and for the period 1950-51 47% and 35% for 184 patients. It appears justified, therefore, to combine the exp_rience of all those who survived operation during the entire 12 years.
Some were reported to have died from causes other than cancer, and in some of these postmortem examination showed no recurrence or metastases. But unless there is a high proportion of necropsies it is impossible to estimate accurately the frequency of non-cancer deaths; no distinction is made in this investigation between death from cancer and death from other diseases. The mortality rates, therefore, are for deaths from all causes. Patients living at the time of the last report were considered to have been alive for half the particular year of observation. The survival rates for the fourth and later years are less likely to be accurate than those for the first three, as the yearly number of operations increased considerably during the later part of the period.
YEARLY SURVIVAL RATES OF THE WHOLE GROUP
These are shown in Table I and Fig. 1 . Four hundred and fifty-three patients survived the early post-operative period. The largest number of deaths occurred in the second three-month period, in which there was a 13% chance of dying. But if the patient survived a year the risk of dying in the subsequent three-month periods declined from 8% to 4% during the next two years. There was a 63 % chance of surviving a year, 47% two years, 39% three years, and 33% five years. Adequate data on the surgeon's assessment of node metastases are available in 233 patients. One hundred of these did not appear to have regional metastases; and the two-year survival rate was 61 %, the five-year rate being 48% (Table II) . On Proportions and rates based on less than 50 patients are printed in italics.
the other hand, of the 133 considered to have metastases, the corresponding rates were 27 % and 11%. The proportion with undifferentiated tumours, that is to say those known to have a lower survival rate, was the same in the two groups (Table IV ). The differences are clearly significant and indicate the great effect of macroscopically evident regional nodes metastases on survival (Table VI) .
Although some of those with histological evidence of metastases also had greatly enlarged nodes, many (Table  III) , as was the proportion with enlarged nodes in the sample investigated (Table IV) . There were, however, differences in the survival rates.
The two-year rate for those with a right-sided tumour was 51 % compared with 44% for those on the left side; and the five-year rates were 39% and 31%.
The survival rates have also been calculated for the different lobes of the lungs (Table II The lowest survival rates were found with left lower lobe tumours, and the differences between this lobe and the others are much less likely to have been chance findings (Table VI) . There were, moreover, insignificant differences in the distribution of histological types between the lobes, and only a very slightly higher proportion of left lower lobe tumours with enlarged nodes in the sample examined. It may be, therefore, that the observed differences in survival rates were indeed due to the situation of the tumour.
SEX.-There were only 41 women among the 453 patients surviving operation. Their two-and five-year survival rates were 65% and 57%, compared with 46% and 31 % for the men, although there was a higher proportion of women with undifferentiated tumours (Tables II and III) . There were, on the other hand, probably fewer women with enlarged nodes, there being 42% compared with 59% in the sample examined. The difference in the survival rates is considerable and was probably not due to chance (Table  VI) . But with such a small number of women and such unequal distribution between the sexes of the two factors known to influence prognosis, it is impossible to be sure that the differences in mortality were due only to sex differences in the behaviour of the tumour.
AGE.-No regular pattern of survival in relation to the age of the patients was detected (Table  II) . Thus, the two-year rates ranged from 39% for those between 45 and 49 years to 55 % between 60 and 64, and the five-year rates from 27% to 40%. But survival did not consistently decrease or increase with advancing age. The proportion with undifferentiated tumours was lower in those over 60 (Table III) . This factor would tend to increase the survival rate; but, although the prognosis was indeed slightly better in those between 60 and 64 than in those between 45 and 60 the difference was small. Those not treated. In a series of 255 untreated patients the median survival time after diagnosis was five months in those who had had symptoms for less than two months; but it fell to three months in the group with four to five months' illness before diagnosis, and rose again to seven months in patients with symptoms for a year or longer (Bignall, 1955b (Table II) . But the differences cannot be attributed to the extent of the resection. The proportion of undifferentiated tumours in the two groups was similar (Table III) . But the sample in which the presence of gross evidence of metastases was investigated suggests that many more who had a lobectomy (as might be expected) had no evidence of node involvement (Table IV) . Sixty per cent. having a lobectomy had no manifestly enlarged nodes compared with only 38% of those who had a pneumonectomy. The twoand five-year survival rates after pneumonectomy when no enlarged nodes were recorded were 64% and 49% (Fig. 3) operation compared with 21 (13 %) of the 163 who had a pneumonectomy. Moreover, during the whole 12-year period only one of the 74 patients treated by lobectomy died in the early post-operative period. The mortality during 1950 and 1951 was 7% in those under 50 years of age, 10% in the sixth decade, and 13% in those over 60. Although these differences are slight, it might be expected that the immediate risk of the operation would increase with age. The operative mortality was higher in those who had a resection done on the right side, being 12% compared with 8% on the left side. Following pneumonectomy the mortality was 16% on the right and 10% on the left. But both differences are small and may have been due to chance (Table V) . It is unlikely that the early prognosis is affected by the side of the lesion.
DISCUSSION
The poorer prognosis of undifferentiated tumours after lung resection is well known (Adams, 1948; McDonald, McBurney, Carlisle, and Patton, 1951 ; Borrie, 1952; Kirklin, McDonald, Clagett, Moersch, and Gage, 1955) . So, too, is the considerable influence of metastases in the regional nodes on survival (Overholt and Schmidt, 1949; Churchill, Sweet, Soutter, and Scannel, 1950; Moore, 1951 ; Carlisle, McDonald, and Harrington, 1951 ; Thompson, 1952; Borrie, 1952; Ochsner, Ray, and Acree, 1954) . Carlisle and others (1951) , from a study of 68 patients with squamous tumours at the Mayo Clinic, concluded that the prognosis was worse when the tumour was in the left lung. Borrie (1952) reported that eight of 13 patients alive three years after operation had had upper lobe lesions, although there had been a greater proportion of lower lobe tumours among the 72 resected. Our investigation also suggests that lower lobe tumours cause death within five years more frequently than those in the upper lobe, the difference between the right and left lungs being largely due to the low survival rate with tumours of the left lower lobe.
A slightly better prognosis with upper lobe tumours might merely be due to certain factors affecting selection for operation. Owing to the nearness of the primary to the supraclavicular nodes, the recurrent laryngeal nerve on the left and the superior vena cava on the right, it might be expected that more patients with upper lobe tumours would be judged unfit for exploration and therefore for resection. In those with lower lobe tumours involvement of regional nodes may have to be much greater before it becomes manifest. That such selection takes place is suggested by the study of 637 unselected patients seen at the Brompton and Royal Marsden Hospitals during 1951 and 1952. The bronchial location of the tumour was known in 505 cases. Two hundred and twenty-seven had cancers in the upper lobe; 53 (23%) had clinical or radiographic evidence of metastases when they were first examined at the hospitals, and 60 (26%) had a resection. On the other hand, only 27 (16%) of 166 with lower lobe cancers had manifest metastases and 57 (34%) had a resection. Furthermore, Borrie (1952) found that there was more node involvement in the resected specimens when the primary was in --~1-.
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_I-1 the lower lobes. Those with upper lobe tumours who have the lung resected are probably, as a group, in a less advanced stage of the disease than those with lower lobe tumours, and the result of operation would be expected to be better.
A possible explanation of the differences between the right and left lower lobes-and to a less extent between the upper lobes-may be found in the anatomy of the lymphatics. Rouviere (1932) states that the lymphatics from the lower third of the left lung, as well as some of the x-essels from the middle third, drain through the bifurcation lymph nodes into the right paratracheal chain. Warren and Drinker (1942) demonstrated in dogs that the greater part of the lymph from both lungs eventually passed into the vessels in the right paratracheal region; only a small amount from the left lung entered the blood stream from the left paratracheal system. The distribution of metastases could not be expected to follow strictly the physiological path of the lymph, for once a pathway becomes blocked bv tumour the lymph stream is probably diverted into other channels. McCort and Robbins (1951) Four hundred and fifty-three survived the early post-operative period. Their chance of surviving one year was 63 %, two years 47 %, and five years 33%.
The two-and five-year rates for those reported to have squamous tumours was 52 % and 36 % compared with 34 % and 26 % for those with undifferentiated growths.
The apparent involvement of the mediastinal nodes at operation had a considerable influence on survival. The two-and five-year rates for those without enlarged nodes were 61 % and 48%, but for those with enlarged nodes the rates were 27 % and 11 %.
The prognosis appeared to depend to some extent on the situation of the tumour. The highest survival rates were observed with cancers of the right upper lobe, the two-year rate being 57%. The left upper and right lower lobes had similar though slightly lower rates. But the two-year rate with cancers of the left lower lobe was significantly lower, being only 36%.
No regular pattern of survival in relation to age was detected.
The prognosis was better in women than in men.
The survival rates were lower in those with symptoms for six to eight months than in those with either shorter or longer histories.
The 
